![]() Cristina holds an MBA from the Wharton School at the University of Pennsylvania and a BA from Haverford College. CONNECT 14 DAY 14 DAY M/ DD / YY H: AM PM 2. Bardy, Rehabilitation // Psychology, special (including therapy for learning, speech. Bardy Diagnostics CAM Quick Reference Instructions Carnation Ambulatory Monitor LED CAUTION: Touching the adhesive can reduce adhesive performance. She started her career in pharmaceutical sales, receiving several national awards during her tenure at both Parke-Davis and Wyeth. diagnostics (DNA chips and biosensing devices for the early/accurate. She has held several other leadership roles at various companies within the medical device industry, including Cordis Cardiology (Cardinal Health) and FoxHollow Technologies (Medtronic). Most recently, Cristina was in charge of market development and sales for the Long-Term Care market at the health technology company MedBridge. ![]() In her 6 years at iRhythm Technologies as their first commercial-facing employee, Cristina built the Marketing team and oversaw all the marketing, sales training, and new markets activities, including the launch of their flagship product, the Zio Patch. With over 20 years of sales and marketing experience within the healthcare industry, Cristina brings extensive experience to the Bardy team in the diagnostic cardiac patch monitoring space. Developed by an electrophysiologist, the Bardy CAM Patch is a long-term ECG monitor that has been clinically proven to find arrhythmias. In addition, he completed his residency at Northwestern University and a fellowship in cardiology and electrophysiology at Duke University. Bardy earned a BS in physics from Carnegie-Mellon University before completing his MD from Northwestern University Medical School. Bardy holds a faculty position as Clinical Professor of Medicine, Cardiology at the University of Washington and is the Director of the Seattle Institute for Cardiac Research. In addition to serving Bardy Diagnostics, Dr. ![]() Bardy’s previous company, Cameron Health, was successfully acquired by Boston Scientific in 2012 for its revolutionary Subcutaneous Implantable Defibrillator (S-ICD) product. patents issued, all of which have been incorporated in cardiac rhythm management technologies in use by many medical device companies. Bardy has also developed technological solutions to patient rhythm problems with over 270 U.S. He has been a researcher and clinician in the field of sudden death and disabling cardiac rhythm disorders for 38 years with over 400 peer-reviewed publications. Bardy has been a cardiac electrophysiologist since 1983 with research interests in cardiac defibrillator technology, cardiac arrest, ablation, heart failure and atrial fibrillation from both a public health and a technical perspective.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |